Clinical Trials Browser

OTHER × Has results × Prostatic Neoplasms × Clear all

NCT03570827 2026-05-26

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Phase 2 Completed

53 enrolled 11 charts

Prostatic Neoplasms

NCT03934840 2026-05-26

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

Phase 2 Completed

61 enrolled 16 charts

Prostatic Neoplasms

NCT01823562 2026-05-20

Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery

Phase 1 Completed

60 enrolled 12 charts

Prostatic Neoplasms

NCT01885949 2026-05-20

Tivozanib + Enzalutamide in Adv Prostate Cancer

Phase 2 Terminated

5 enrolled 8 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT04037254 2026-05-20

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Phase 1/2 Completed

22 enrolled 13 charts

Prostatic Neoplasms

NCT00183937 2026-05-15

Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer

Phase 2 Terminated

15 enrolled 11 charts

Prostatic Neoplasms

NCT04019964 2026-05-15

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

Phase 2 Completed

8 enrolled 12 charts

Prostatic Neoplasms

NCT04716725 2026-05-15

68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

Phase 2 Terminated

15 enrolled 10 charts

Prostatic Neoplasms

NCT05730712 2026-05-15

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

7 enrolled 10 charts

Prostatic Neoplasms

NCT02312557 2026-05-14

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Phase 2 Active not recruiting

58 enrolled 13 charts

Prostatic Neoplasms

NCT03644303 2026-05-14

TRAP

Phase NA Completed

86 enrolled 27 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT04030559 2026-05-14

Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects

Phase 2 Terminated

11 enrolled 7 charts

Prostatic Neoplasms

NCT01624220 2026-05-12

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Phase NA Completed

41 enrolled 8 charts

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Prostatic Neoplasms, Sarcoma, Spinal Cord Neoplasms, Thyroid Neoplasms

NCT04731844 2026-05-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Phase 2 Completed

30 enrolled 13 charts

GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms

NCT04262154 2026-05-11

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Phase 2 Active not recruiting

28 enrolled 9 charts

Prostatic Neoplasms

NCT03637543 2026-05-08

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

Phase 2 Active not recruiting

29 enrolled 13 charts

Prostatic Neoplasms

NCT04565457 2026-05-06

A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality

Phase NA Completed

43 enrolled 17 charts

GenitourinaryHead & Neck

Head and Neck Neoplasms, Prostatic Neoplasms

NCT05375539 2026-05-06

AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients

Phase 1 Completed

12 enrolled 13 charts

Prostatic Neoplasms

NCT01411345 2026-05-05

MAPS

Phase NA Active not recruiting

37 enrolled 10 charts

Prostatic Neoplasms

NCT03217747 2026-05-05

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

Phase 1/2 Active not recruiting

173 enrolled 28 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT04631744 2026-05-01

Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Phase 2 Terminated

4 enrolled 11 charts

Prostatic Neoplasms

NCT06630325 2026-04-28

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Terminated

6 enrolled 3 charts

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT02555189 2026-04-22

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Phase 1/2 Terminated

52 enrolled 31 charts

Prostatic Neoplasms

NCT03935282 2026-04-15

AH-HA

Phase NA Completed

645 enrolled 43 charts

BreastGastrointestinalGenitourinaryGynecologicLymphoid

Breast Neoplasms, Cardiovascular Diseases, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Health Behavior, Endometrial Neoplasms

NCT02772588 2026-04-13

AASUR in High Risk Prostate Cancer

Phase 2 Completed

64 enrolled 7 charts

Prostatic Neoplasms

NCT00859781 2026-04-08

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Phase 2 Active not recruiting

55 enrolled 11 charts

Prostatic Neoplasms

NCT03660085 2026-04-03

PC-PEP

Phase NA Completed

140 enrolled 8 charts

Psychological Well-Being, Motor Activity, Prostatic Neoplasms

NCT03496805 2026-03-31

Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy

Phase 2 Completed

106 enrolled 10 charts

Prostatic Neoplasms

NCT04461509 2026-03-25

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Phase 2 Completed

62 enrolled 11 charts

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT05678322 2026-03-25

Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy

Phase 3 Active not recruiting

26 enrolled 7 charts

Prostatic Neoplasms

NCT04905082 2026-03-24

HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

Phase NA Active not recruiting

465 enrolled 11 charts

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT03787680 2026-03-23

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Phase 2 Active not recruiting

49 enrolled 11 charts

Prostatic Neoplasms

NCT03412396 2026-03-19

Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy

Phase 2 Active not recruiting

45 enrolled 10 charts

Prostatic Neoplasms

NCT03663218 2026-03-18

PREPARE SBRT

Phase NA Active not recruiting

16 enrolled 9 charts

Prostatic Neoplasms

NCT01804712 2026-03-12

Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy

Phase EARLY_PHASE1 Completed

8 enrolled 12 charts

Neoplasms, Prostatic Neoplasms

NCT03778112 2026-03-09

MRI Guided SBRT for Localized Prostate Cancer

Phase NA Active not recruiting

54 enrolled 9 charts

Prostatic Neoplasms

NCT03808077 2026-03-09

The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer

Phase 2 Active not recruiting

139 enrolled 9 charts

Muscle Hypotonia, Prostatic Neoplasms

NCT05764005 2026-03-06

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

Phase NA Completed

39 enrolled 9 charts

Prostatic Neoplasms

NCT02946996 2026-03-05

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Phase 2 Terminated

41 enrolled 8 charts

Prostatic Neoplasms

NCT02522715 2026-02-24

Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

Phase 1/2 Active not recruiting

37 enrolled 10 charts

Prostatic Neoplasms

NCT03254420 2026-02-20

RCMIGI

Phase NA Active not recruiting

74 enrolled 11 charts

Prostatic Neoplasms

NCT04751929 2026-02-20

Abemaciclib With or Without Atezolizumab for mCRPC

Phase 2 Active not recruiting

19 enrolled 13 charts

Prostatic Neoplasms

NCT00809991 2026-02-18

Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate

Phase 2 Completed

91 enrolled 12 charts

Prostatic Neoplasms

NCT02274779 2026-02-13

OLIGOPELVIS

Phase 2 Completed

74 enrolled 6 charts

Prostatic Neoplasms

NCT05320406 2026-02-12

REVELUTION

Phase 2 Active not recruiting

94 enrolled 13 charts

Prostatic Neoplasms

NCT05366842 2026-01-30

Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care

Phase 2 Terminated

3 enrolled 5 charts

Erectile Dysfunction, Prostatic Neoplasms

NCT03553602 2026-01-29

BEACON

Phase 1/2 Terminated

3 enrolled 7 charts

Prostatic Neoplasms

NCT03796767 2026-01-28

SOAR

Phase 2 Active not recruiting

20 enrolled 26 charts

Lymphatic Metastasis, Prostatic Neoplasms

NCT03565835 2026-01-26

Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

Phase 2 Completed

31 enrolled 11 charts

Prostatic Neoplasms

NCT03246347 2026-01-23

A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer

Phase 2 Active not recruiting

40 enrolled 12 charts

Prostatic Neoplasms